Literature DB >> 9630057

Prevalence of antibodies specific to Puumala virus among farmers in Sweden.

C Ahlm1, A Thelin, F Elgh, P Juto, E L Stiernström, S Holmberg, A Tärnvik.   

Abstract

OBJECTIVES: The Puumala virus is the causative agent of nephropathia epidemica, a European form of hemorrhagic fever with a renal syndrome. From its reservoir in bank voles, the virus is spread by airborne transmission to humans. Occupational risks for the acquisition of nephropathia epidemica are not well defined. The prevalence of serum antibodies to Puumala virus was determined for Swedish farmers. From a comparison of the prevalence among farmers from various parts of the country, the assumption that Puumala virus occurs endemically only in the northern and central parts of Sweden was also tested.
METHODS: Serum samples from 910 farmers and 663 referents living in various rural parts of Sweden were tested with an enzyme-linked immunosorbent assay, using a recombinant nucleocapsid protein of Puumala virus as the antigen.
RESULTS: North of a latitude of 59 degrees N, the prevalence of Puumala virus antibodies was significantly higher among farmers (12.9%) than among referents (6.8%). In the southern areas, antibodies to Puumala virus were rare, and altogether only 2 of 459 persons had antibodies. Seropositive persons did not differ from seronegative ones with regard to blood pressure, and they did not comprise cases of chronic renal disease.
CONCLUSIONS: Serological evidence confirmed that the exposure of humans to Puumala virus is firmly restricted to the northern and central parts of Sweden. In addition the evidence indicated that, in this region, farming is associated with an increased risk of contracting hantavirus infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630057     DOI: 10.5271/sjweh.286

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  7 in total

1.  Early diagnosis of hantavirus infection by family doctors can reduce inappropriate antibiotic use and hospitalization.

Authors:  Alette Brorstad; Kristina Bergstedt Oscarsson; Clas Ahlm
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

Review 2.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study.

Authors:  Alin Gherasim; Marika Hjertqvist; Åke Lundkvist; Sharon Kühlmann-Berenzon; Jenny Verner Carlson; Stephan Stenmark; Mikael Widerström; Anders Österlund; Hans Boman; Clas Ahlm; Anders Wallensten
Journal:  Infect Ecol Epidemiol       Date:  2015-06-30

4.  Prevalence of antibodies against hantaviruses in serum and saliva of adults living or working on farms in Yorkshire, United Kingdom.

Authors:  Lisa J Jameson; Autilia Newton; Louise Coole; Edmund N C Newman; Miles W Carroll; Nick J Beeching; Roger Hewson; Robert M Christley
Journal:  Viruses       Date:  2014-02-05       Impact factor: 5.048

5.  Human Puumala hantavirus infection in northern Sweden; increased seroprevalence and association to risk and health factors.

Authors:  Kristina Bergstedt Oscarsson; Alette Brorstad; Maria Baudin; Anne Lindberg; Annika Forssén; Magnus Evander; Marie Eriksson; Clas Ahlm
Journal:  BMC Infect Dis       Date:  2016-10-13       Impact factor: 3.090

6.  Preliminary insights into the genetics of bank vole tolerance to Puumala hantavirus in Sweden.

Authors:  Audrey Rohfritsch; Maxime Galan; Mathieu Gautier; Karim Gharbi; Gert Olsson; Bernhard Gschloessl; Caroline Zeimes; Sophie VanWambeke; Renaud Vitalis; Nathalie Charbonnel
Journal:  Ecol Evol       Date:  2018-10-26       Impact factor: 2.912

7.  Occupational Hantavirus Infections in Agricultural and Forestry Workers: A Systematic Review and Metanalysis.

Authors:  Matteo Riccò; Simona Peruzzi; Silvia Ranzieri; Nicola Magnavita
Journal:  Viruses       Date:  2021-10-25       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.